Not logged in Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study Solitano, Virginia; Ogunsakin, Ropo Ebenezer; Yuan, Yuhong; Bernstein, Charles N.; Bessissow, Talat; Bressler, Brian; Hoentjen, Frank; Van Lierop, Lisa; Leung, Yvette; Ma, Christopher; Marshall, John Kenneth; Narula, Neeraj; Alahmari, Mohammed; Mccurdy, Jeffrey D.; Murthy, Sanjay; Panaccione, Remo; Rosenfeld, Greg; Milgrom, Raquel; Silverberg, Mark; Jairath, Vipul Share Save
Share Save
Effectiveness and Safety of Advanced Combination Treatment (ACT) in patients with refractory inflammatory bowel disease or concomitant immune mediated disease or extra-intestinal manifestations: A Multi-Center Canadian Study Solitano, V; Ogunsakin, R. E.; Yuan, Y.; Bernstein, C. N.; Bessisow, T.; Bressler, B.; Hoentjen, F.; van Lierop, L.; Leung, Y.; Ma, C.; Marshall, J. K.; Narula, N.; Alahmari, M.; Mccurdy, J.; Murthy, S.; Panaccione, R.; Milgrom, R.; Rosenfeld, G.; Silverberg, M.; Jairath, V Share Save
Effectiveness of second-and-third line biologics in perianal Crohn's disease (pCD) - a multicenter propensity score-matched study Shani, U.; State, M.; Mateescu, R. B.; Davidoiu, A. M.; Negreanu, L.; Silva, I; Magro, E.; Plevris, N.; Roblin, X.; Castellet-Farrus, S.; Lama, Y. Gonzalez; Wang, S.; Abad, C.; Imperatore, N.; Lukas, M.; Vojtechova, G.; Ukashi, O.; Nancey, S.; Savarino, E.; Stawczyk-Eder, K.; Eder, P.; Toskas, A.; Kamperidis, N.; Arebi, N.; Farkas, B.; Farkas, K.; Pipek, B.; Falt, P.; Karmiris, K.; Nikolaou, P.; Krznaric, Z.; Brinar, M.; van Lierop, L.; Barreiro-de Acosta, M.; Zaborowska, M.; Zagorowicz, E.; Pugliese, D.; Cuccia, G.; Truyens, M.; Kopylov, U. Share Save
Long-term effectiveness and safety of ustekinumab dose escalation in patients with refractory ulcerative colitis: a multicenter retrospective cohort study Van Lierop, L.; Albino, L.; Rosentreter, R.; Thomas, P. W. A.; Lu, C.; Siffledeen, J.; Kroeker, K., I; Ma, C.; Peerani, F.; Halloran, B. P.; Baumgart, D. C.; Dieleman, L. A.; Du, L.; Hoentjen, F.; Wong, K. Share Save
Long-term outcomes of extended versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial Devillers, M.; van Lierop, L.; van Linschoten, R.; Jansen, F.; den Broeder, N.; de Jong, D.; Bodelier, A.; West, R.; Gisbertz, I; Romkens, T.; Boekema, P.; Lutgens, M.; Mujagic, Z.; Wolfhagen, F.; de Boer, N.; Oldenburg, B.; van Bodegraven, A.; Mallant-Hent, R.; van der Meulen-de Jong, A.; ter Borg, P.; Braat, H.; Jansen, J.; Tan, A.; Jansen, S.; van der Woude, J.; de Vries, A.; Hoentjen, F. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}